Back

Mineralocorticoid receptor antagonist therapy in patients with ischemic heart failure and ventricular tachycardia: a comparative analysis of spironolactone vs. eplerenone

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Ventricular arrhythmias: novel insights Drug Treatment of Ventricular Arrhythmias ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Imre Szakal

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

8 More presentations in this session

Presentation thumbnail
Prospective assessment of risk factors for appropriate ICD intervention in patients with ischemic cardiomyopathy: results of PARCADIA trial
Mr L. Voorhout (Arnhem, NL)
Abstract Slides Video
Presentation thumbnail
The relative importance of ischaemia and scar in the genesis of ventricular arrhythmia in ischaemic cardiomyopathy
Doctor H. Morgan (London, GB)
Abstract Slides Video
Presentation thumbnail
Predictor of wasted implantable cardioverter defibrillator for secondary prevention
Doctor R. Akagawa (Niigata, JP)
Abstract Slides Video
Presentation thumbnail
Right ventricular outflow tract arrhythmias in patients with obstructive sleep apnea- electrophysiological insights
Doctor A. Negru (Timisoara, RO)
Abstract Slides Video
Presentation thumbnail
Low levels of apolipoprotein M are associated with increased risk of ventricular arrhythmias
Associate Professor P. Myhre (Oslo, NO)
Abstract Slides Video

Access the full session

Session thumbnail
Ventricular arrhythmias: novel insights

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Comparison of eplerenone and spironolactone treatment in patients with ischemic heart disease hospitalized due to ventricular tachycardia
thumbnail
Congress Presentation
Catheter ablation versus antiarrhythmic drugs in patients with ventricular tachycardia and ischemic cardiomyopathy: a meta-analysis of randomized controlled trials
thumbnail
Congress Presentation
Comparison of ventricular tachyarrhythmias in HF patients on dapagliflozin versus empagliflozin

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources